• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病的诊断与分期

Diagnosis and staging of Alzheimer disease.

作者信息

Duyckaerts C, Hauw J J

机构信息

Laboratoire de Neuropathologie R. Escourolle, Hôpital de La Salpêtrière, Paris, France.

出版信息

Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S33-42. doi: 10.1016/s0197-4580(97)00067-5.

DOI:10.1016/s0197-4580(97)00067-5
PMID:9330983
Abstract

Rather than determining lesions "threshold" between "normal" cases and patients, we prefer to use clinicopathological correlations, assigning a given intellectual deficit to a given amount of lesions with a chosen level of probability. Because large amounts of A beta diffuse deposits may be found in the absence of dementia, we think advisable not to take them into account for the diagnosis. The diffusion of the neurofibrillary tangles in the paralimbic, limbic and isocortical areas (described by braak and Braak stages or by the number of areas containing tangles) and the density of isocortical senile plaques (A beta focal deposits) as assessed by the CERAD protocol are both correlated with the intellectual status but give complementary information. They should thus be jointly used. We analyzed the variability of the lesions counts, their coefficients of error, and their causes, as a first step toward standardization. We have shown, however, that semiquantitative estimates are presently more reproducible than quantitative measures.

摘要

我们更倾向于使用临床病理相关性,而不是确定“正常”病例与患者之间病变的“阈值”,即将特定的智力缺陷与特定数量的病变以选定的概率水平相关联。由于在没有痴呆的情况下可能会发现大量β淀粉样蛋白弥漫性沉积,我们认为在诊断时不考虑它们是明智的。神经原纤维缠结在边缘旁、边缘和等皮质区域的扩散(由Braak和Braak分期或含有缠结的区域数量描述)以及通过CERAD方案评估的等皮质老年斑(β淀粉样蛋白局灶性沉积)密度均与智力状态相关,但提供互补信息。因此,它们应联合使用。作为标准化的第一步,我们分析了病变计数的变异性、其误差系数及其原因。然而,我们已经表明,目前半定量估计比定量测量更具可重复性。

相似文献

1
Diagnosis and staging of Alzheimer disease.阿尔茨海默病的诊断与分期
Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S33-42. doi: 10.1016/s0197-4580(97)00067-5.
2
Position paper on diagnostic criteria for Alzheimer disease.关于阿尔茨海默病诊断标准的立场文件。
Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S71-3. doi: 10.1016/s0197-4580(97)00073-0.
3
The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies.阿尔茨海默病的神经病理学诊断:临床病理研究
Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S27-32. doi: 10.1016/s0197-4580(97)00066-3.
4
Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies.阿尔茨海默病的神经病理学诊断:来自纵向临床病理学研究的视角
Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S21-6. doi: 10.1016/s0197-4580(97)00065-1.
5
Neuropathology of cognitively normal elderly.认知正常老年人的神经病理学
J Neuropathol Exp Neurol. 2003 Nov;62(11):1087-95. doi: 10.1093/jnen/62.11.1087.
6
Neuropathological criteria for the diagnosis of Alzheimer's disease.阿尔茨海默病诊断的神经病理学标准。
Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S13-9. doi: 10.1016/s0197-4580(97)00064-x.
7
Diagnostic criteria for neuropathologic assessment of Alzheimer's disease.
Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S85-8. doi: 10.1016/s0197-4580(97)00062-6.
8
Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.美国国立衰老研究所(NIA)-里根研究所标准在阿尔茨海默病神经病理学诊断中的应用。
J Neuropathol Exp Neurol. 1999 Nov;58(11):1147-55. doi: 10.1097/00005072-199911000-00004.
9
Frequency of stages of Alzheimer-related lesions in different age categories: concurrences and cautions.
Neurobiol Aging. 1997 Jul-Aug;18(4):375-6; discussion 389-92. doi: 10.1016/s0197-4580(97)00052-3.
10
Practical measures to simplify the Braak tangle staging method for routine pathological screening.简化用于常规病理筛查的Braak神经缠结分期方法的实用措施。
Acta Neuropathol. 2000 Feb;99(2):199-208. doi: 10.1007/pl00007425.

引用本文的文献

1
A walk through tau therapeutic strategies.穿越 tau 治疗策略的漫步。
Acta Neuropathol Commun. 2019 Feb 15;7(1):22. doi: 10.1186/s40478-019-0664-z.
2
Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology.阿尔茨海默病(AD)相关tau细胞骨架病理学的皮质前期
Brain Pathol. 2016 May;26(3):371-86. doi: 10.1111/bpa.12289. Epub 2015 Aug 24.
3
Effect of Different Phospholipids on α-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer's Disease.不同磷脂对阿尔茨海默病非淀粉样蛋白生成途径中 α-分泌酶活性的影响。
Int J Mol Sci. 2013 Mar 13;14(3):5879-98. doi: 10.3390/ijms14035879.
4
Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease.外泌体对阿尔茨海默病中病变的朊病毒样传播的潜在贡献。
Front Physiol. 2012 Jul 5;3:229. doi: 10.3389/fphys.2012.00229. eCollection 2012.
5
Adult-onset focal expression of mutated human tau in the hippocampus impairs spatial working memory of rats.成年期海马体中突变型人 tau 的局灶性表达损害大鼠的空间工作记忆。
Behav Brain Res. 2012 Jul 15;233(1):141-8. doi: 10.1016/j.bbr.2012.04.034. Epub 2012 Apr 25.
6
Clinico-pathological correlations of the most common neurodegenerative dementias.最常见神经退行性痴呆的临床病理相关性
Front Neurol. 2012 May 1;3:68. doi: 10.3389/fneur.2012.00068. eCollection 2012.
7
Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults.老年人群体中两个基于社区的队列中多种认知功能的神经病理学相关性。
J Int Neuropsychol Soc. 2011 Jul;17(4):602-14. doi: 10.1017/S1355617710001426.
8
FAD mutations in amyloid precursor protein do not directly perturb intracellular calcium homeostasis.淀粉样前体蛋白中的 FAD 突变不会直接扰乱细胞内钙离子稳态。
PLoS One. 2010 Aug 5;5(8):e11992. doi: 10.1371/journal.pone.0011992.
9
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.一个大型阿尔茨海默病中心尸检队列中的临床病理相关性:在对疾病严重程度进行分期时,神经炎性斑块和神经原纤维缠结“确实重要”。
J Neuropathol Exp Neurol. 2007 Dec;66(12):1136-46. doi: 10.1097/nen.0b013e31815c5efb.
10
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.使用石蜡切片和免疫细胞化学对阿尔茨海默病相关神经原纤维病变进行分期。
Acta Neuropathol. 2006 Oct;112(4):389-404. doi: 10.1007/s00401-006-0127-z. Epub 2006 Aug 12.